Cargando…
Long COVID: The latest manifestations, mechanisms, and potential therapeutic interventions
COVID‐19 caused by SARS‐CoV‐2 infection affects humans not only during the acute phase of the infection, but also several weeks to 2 years after the recovery. SARS‐CoV‐2 infects a variety of cells in the human body, including lung cells, intestinal cells, vascular endothelial cells, olfactory epithe...
Autores principales: | He, Shi‐ting, Wu, Kexin, Cheng, Zixuan, He, Mengjie, Hu, Ruolan, Fan, Ning, Shen, Lin, Li, Qirui, Fan, Huahao, Tong, Yigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732402/ https://www.ncbi.nlm.nih.gov/pubmed/36514781 http://dx.doi.org/10.1002/mco2.196 |
Ejemplares similares
-
2’-Fucosyllactose Inhibits Coxsackievirus Class A Type 9 Infection by Blocking Virus Attachment and Internalisation
por: Lou, Fuxing, et al.
Publicado: (2022) -
Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae
por: Han, Pengjun, et al.
Publicado: (2023) -
Unveil the Secret of the Bacteria and Phage Arms Race
por: Wang, Yuer, et al.
Publicado: (2023) -
Identification of a novel family B DNA polymerase from Enterococcus phage IME199 and its overproduction in Escherichia coli BL21(DE3)
por: Han, Pengjun, et al.
Publicado: (2023) -
Pharmacological Activity of Cepharanthine
por: Liu, Ke, et al.
Publicado: (2023)